Works matching AU Andreone, Pietro


Results: 80
    1

    Effectiveness and safety of switching to entecavir hepatitis B patients developing kidney dysfunction during tenofovir.

    Published in:
    Liver International, 2019, v. 39, n. 3, p. 484, doi. 10.1111/liv.14017
    By:
    • Viganò, Mauro;
    • Labanca, Sara;
    • Occhipinti, Vincenzo;
    • Rumi, Mariagrazia;
    • Marzano, Alfredo;
    • Tucci, Alessandra;
    • Taliani, Gloria;
    • Fasano, Massimo;
    • Fagiuoli, Stefano;
    • Villa, Erica;
    • Bronte, Fabrizio;
    • Santantonio, Teresa;
    • Brancaccio, Giuseppina;
    • Loglio, Alessandro;
    • Facchetti, Floriana;
    • Grossi, Glenda;
    • Lampertico, Pietro;
    • Zaltron, Serena;
    • Castelli, Francesco;
    • Andreone, Pietro
    Publication type:
    Article
    2
    3

    Vitamin E for the treatment of E-antigen-positive chronic hepatitis B in paediatric patients: results of a randomized phase 2 controlled study.

    Published in:
    Liver International, 2017, v. 37, n. 1, p. 54, doi. 10.1111/liv.13192
    By:
    • Fiorino, Sirio;
    • Loggi, Elisabetta;
    • Verucchi, Gabriella;
    • Comparcola, Donatella;
    • Vukotic, Ranka;
    • Pavoni, Michele;
    • Grandini, Elena;
    • Cursaro, Carmela;
    • Maselli, Silvia;
    • Bacchi Reggiani, Maria L.;
    • Puggioli, Cristina;
    • Badia, Lorenzo;
    • Galli, Silvia;
    • Viale, Pierluigi;
    • Bernardi, Mauro;
    • Andreone, Pietro
    Publication type:
    Article
    4

    Low-density lipoprotein and other predictors of response with telaprevir-based therapy in treatment-experienced HCV genotype 1 patients: REALIZE study.

    Published in:
    Liver International, 2015, v. 35, n. 2, p. 448, doi. 10.1111/liv.12703
    By:
    • Berg, Thomas;
    • Andreone, Pietro;
    • Pol, Stanislas;
    • Roberts, Stuart;
    • Younossi, Zobair;
    • Diago, Moises;
    • Lawitz, Eric J.;
    • Focaccia, Roberto;
    • Foster, Graham R.;
    • Horban, Andrzej;
    • Lonjon ‐ Domanec, Isabelle;
    • DeMasi, Ralph;
    • Picchio, Gaston;
    • Luo, Donghan;
    • De Meyer, Sandra;
    • Zeuzem, Stefan
    Publication type:
    Article
    5

    A new prognostic model to predict dropout from the waiting list in cirrhotic candidates for liver transplantation with MELD score <18.

    Published in:
    Liver International, 2015, v. 35, n. 1, p. 184, doi. 10.1111/liv.12538
    By:
    • Biselli, Maurizio;
    • Dall'Agata, Marco;
    • Gramenzi, Annagiulia;
    • Gitto, Stefano;
    • Liberati, Caterina;
    • Brodosi, Lucia;
    • Ravaioli, Matteo;
    • Gambato, Martina;
    • Montalti, Roberto;
    • Pinna, Antonio D.;
    • Burra, Patrizia;
    • Gerunda, Giorgio E.;
    • Cillo, Umberto;
    • Andreone, Pietro;
    • Bernardi, Mauro
    Publication type:
    Article
    6

    DAUPHINE: a randomized phase II study of danoprevir/ritonavir plus peginterferon alpha-2a/ribavirin in HCV genotypes 1 or 4.

    Published in:
    Liver International, 2015, v. 35, n. 1, p. 108, doi. 10.1111/liv.12471
    By:
    • Everson, Gregory;
    • Cooper, Curtis;
    • Hézode, Christophe;
    • Shiffman, Mitchell L.;
    • Yoshida, Eric;
    • Beltran ‐ Jaramillo, Teresita;
    • Andreone, Pietro;
    • Bruno, Savino;
    • Ferenci, Peter;
    • Zeuzem, Stefan;
    • Brunda, Michael;
    • Le Pogam, Sophie;
    • Nájera, Isabel;
    • Zhou, Julian;
    • Navarro, Mercidita T.;
    • Voulgari, Athina;
    • Shulman, Nancy S.;
    • Yetzer, Ellen S.
    Publication type:
    Article
    7
    8
    9
    10

    Validation and refinement of PROSASH model using the neutrophil-to-lymphocyte ratio in patients with HCC receiving sorafenib.

    Published in:
    Liver Cancer International, 2020, v. 1, n. 1, p. 6, doi. 10.1002/lci2.12
    By:
    • Casadei-Gardini, Andrea;
    • Cabibbo, Giuseppe;
    • Dadduzio, Vincenzo;
    • Orsi, Giulia;
    • Vukotic, Ranka;
    • Rizzato, Mario Domenico;
    • Rossi, Margherita;
    • Guarneri, Valeria;
    • Lonardi, Sara;
    • D'Agostino, Dario;
    • Rovesti, Giulia;
    • Rimini, Margherita;
    • Celsa, Ciro;
    • Andreone, Pietro;
    • Zagonel, Vittorina;
    • Scartozzi, Mario;
    • Johnson, Philip;
    • Cascinu, Stefano;
    • Cucchetti, Alessandro
    Publication type:
    Article
    11
    12
    13
    14
    15
    16
    17
    18
    19

    Treatments for HBV: A Glimpse into the Future.

    Published in:
    Viruses (1999-4915), 2021, v. 13, n. 9, p. 1767, doi. 10.3390/v13091767
    By:
    • Bartoli, Alessandra;
    • Gabrielli, Filippo;
    • Tassi, Andrea;
    • Cursaro, Carmela;
    • Pinelli, Ambra;
    • Andreone, Pietro
    Publication type:
    Article
    20

    Hepatitis B Virus-Related Cryoglobulinemic Vasculitis: Review of the Literature and Long-Term Follow-Up Analysis of 18 Patients Treated with Nucleos(t)ide Analogues from the Italian Study Group of Cryoglobulinemia (GISC).

    Published in:
    Viruses (1999-4915), 2021, v. 13, n. 6, p. 1032, doi. 10.3390/v13061032
    By:
    • Mazzaro, Cesare;
    • Maso, Luigino Dal;
    • Gragnani, Laura;
    • Visentini, Marcella;
    • Saccardo, Francesco;
    • Filippini, Davide;
    • Andreone, Pietro;
    • Zignego, Anna Linda;
    • Gattei, Valter;
    • Monti, Giuseppe;
    • Galli, Massimo;
    • Quartuccio, Luca
    Publication type:
    Article
    21

    Successful Direct Acting Antiviral Therapy in Chronic Hepatitis C Normalizes IFNγ and IL2 Production in T Cells Together with TLR8 Expression and Functionality in Peripheral Blood Mononuclear Cells.

    Published in:
    Viruses (1999-4915), 2021, v. 13, n. 4, p. 635, doi. 10.3390/v13040635
    By:
    • Arias-Loste, María Teresa;
    • Cabezas, Joaquín;
    • Llerena, Susana;
    • Iruzubieta, Paula;
    • San-Segundo, David;
    • Merino, David;
    • Cuadrado, Antonio;
    • Vaqué, José Pedro;
    • López-Hoyos, Marcos;
    • Crespo, Javier;
    • Andreone, Pietro;
    • Brillanti, Stefano
    Publication type:
    Article
    22

    HCVerso1 and 2: faldaprevir with deleobuvir (BI 207127) and ribavirin for treatment-naïve patients with chronic hepatitis C virus genotype-1b infection.

    Published in:
    Clinical & Experimental Gastroenterology, 2016, v. 9, p. 351, doi. 10.2147/CEG.S111116
    By:
    • Sarrazin, Christoph;
    • Castelli, Francesco;
    • Andreone, Pietro;
    • Buti, Maria;
    • Colombo, Massimo;
    • Pol, Stanislas;
    • Calinas, Filipe;
    • Puoti, Massimo;
    • Olveira, Antonio;
    • Shiffman, Mitchell;
    • Stern, Jerry O.;
    • Kukolj, George;
    • Roehrle, Michael;
    • Aslanyan, Stella;
    • Qiqi Deng;
    • Vinisko, Richard;
    • Mensa, Federico J.;
    • Nelson, David R.
    Publication type:
    Article
    23

    Lack of Correlation Between Serum Anti-HBcore Detectability and Hepatocellular Carcinoma in Patients With HCV-Related Cirrhosis.

    Published in:
    American Journal of Gastroenterology (Springer Nature), 2008, v. 103, n. 8, p. 1966, doi. 10.1111/j.1572-0241.2008.01912.x
    By:
    • Stroffolini, Tommaso;
    • Almasio, Piero Luigi;
    • Persico, Marcello;
    • Bollani, Simona;
    • Benvegn, Luisa;
    • Di Costanzo, GiovanGiuseppe;
    • Pastore, Giuseppe;
    • Aghemo, Alessio;
    • Stornaiuolo, Gianfranca;
    • Mangia, Alessandra;
    • Andreone, Pietro;
    • Stanzione, Maria;
    • Mazzella, Giuseppe;
    • Saracco, Giorgio;
    • Del Poggio, Paolo;
    • Bruno, Savino
    Publication type:
    Article
    24
    25
    26
    27

    Metronomic Capecitabine in Advanced Hepatocellular Carcinoma Patients: A Phase II Study.

    Published in:
    Oncologist, 2013, v. 18, n. 12, p. 1256, doi. 10.1634/theoncologist.2013-0093
    By:
    • Brandi, Giovanni;
    • Rosa, Francesco;
    • Agostini, Valentina;
    • Girolamo, Stefania;
    • Andreone, Pietro;
    • Bolondi, Luigi;
    • Serra, Carla;
    • Sama, Claudia;
    • Golfieri, Rita;
    • Gramenzi, Annagiulia;
    • Cucchetti, Alessandro;
    • Pinna, Antonio Daniele;
    • Trevisani, Franco;
    • Biasco, Guido
    Publication type:
    Article
    28

    Investigating Acute Hepatitis after SARS-CoV-2 Vaccination or Infection: A Genetic Case Series.

    Published in:
    Biomedicines, 2023, v. 11, n. 10, p. 2848, doi. 10.3390/biomedicines11102848
    By:
    • Bernasconi, Elisa;
    • Biagi, Matteo;
    • Di Agostino, Stefania;
    • Cursaro, Carmela;
    • Felicani, Cristina;
    • Ronconi, Enrico;
    • Franchi, Elena;
    • Costanzo, Arianna Carmen;
    • Gabrielli, Filippo;
    • Cavicchioli, Alessia;
    • Ienopoli, Giuseppe;
    • Marenghi, Paolo;
    • Bartoli, Alessandra;
    • Serra, Beatrice;
    • Scalabrini, Davide;
    • Sighinolfi, Pamela;
    • Andreone, Pietro
    Publication type:
    Article
    29

    Efficacy and Safety of 144 Weeks of Bulevirtide 2 mg or 10 mg Monotherapy from the Ongoing Phase 3 Study MYR301.

    Published in:
    Gut & Liver, 2024, v. 18, p. 109
    By:
    • Lampertico, Pietro;
    • Aleman, Soo;
    • Brunetto, Maurizia;
    • Blank, Antje;
    • Andreone, Pietro;
    • Bogomolov, Pavel;
    • Chulanov, Vladimir;
    • Mamonova, Nina;
    • Geyvandova, Natalia;
    • Viacheslav, Morozov;
    • Sagalova, Olga;
    • Stepanova, Tatyana;
    • Chee, Grace M.;
    • Manuilov, Dmitry;
    • Mingyang Li;
    • Lau, Audrey;
    • Osinusi, Anu;
    • Zur Wiesch, Julian Schulze;
    • Cornberg, Markus;
    • Zeuzem, Stefan
    Publication type:
    Article
    30
    31
    32
    33

    Physical activity in liver transplant recipients: a large multicenter study.

    Published in:
    Internal & Emergency Medicine, 2024, v. 19, n. 2, p. 343, doi. 10.1007/s11739-023-03474-7
    By:
    • Gitto, Stefano;
    • Golfieri, Lucia;
    • Gabrielli, Filippo;
    • Falcini, Margherita;
    • Sofi, Francesco;
    • Tamè, Maria Rosa;
    • De Maria, Nicola;
    • Marzi, Luca;
    • Mega, Andrea;
    • Valente, Giovanna;
    • Borghi, Alberto;
    • Forte, Paolo;
    • Cescon, Matteo;
    • Di Benedetto, Fabrizio;
    • Andreone, Pietro;
    • Petranelli, Marco;
    • Morelli, Maria Cristina;
    • De Simone, Paolo;
    • Lau, Chloe;
    • Stefani, Laura
    Publication type:
    Article
    34
    35

    Gross Pathologic Types of Hepatocellular Carcinoma in Italy.

    Published in:
    Oncology, 1999, v. 56, n. 3, p. 189, doi. 10.1159/000011963
    By:
    • Stroffolini, Tommaso;
    • Andreone, Pietro;
    • Andriulli, Angelo;
    • Ascione, Antonio;
    • Craxì, Antonio;
    • Chiaramonte, Maria;
    • Galante, Domenico;
    • Manghisi, Onofrio Giuseppe;
    • Mazzanti, Roberto;
    • Medaglia, Cinzia;
    • Pilleri, Giampaolo;
    • Rapaccini, Gian Ludovico;
    • Albanese, Maddalena;
    • Taliani, Gloria;
    • Tosti, Maria Elena;
    • Villa, Erica;
    • Gasbarrini, Giovanni
    Publication type:
    Article
    36

    miRNA Expression and HCC Occurrence in HCV Cirrhotic Patients Treated with Direct Acting Antivirals.

    Published in:
    Livers, 2024, v. 4, n. 2, p. 275, doi. 10.3390/livers4020020
    By:
    • Romano, Antonietta;
    • Brocca, Alessandra;
    • Mariño, Zoe;
    • Pérez-del-Pulgar, Sofía;
    • Lens, Sabela;
    • Boix, Loreto;
    • Reig, María;
    • Bruix, Jordi;
    • Ceolotto, Giulio;
    • Calvino, Valeria;
    • Zilio, Gianluca;
    • Romero, Paula Piñero;
    • Vukotic, Ranka;
    • Guarneri, Valeria;
    • Andreone, Pietro;
    • Parisi, Saverio Giuseppe;
    • Russo, Francesco Paolo;
    • Piano, Salvatore;
    • Cillo, Umberto;
    • Angeli, Paolo
    Publication type:
    Article
    37
    38

    A randomized trial of induction doses of interferon alone or in combination with ribavirin or ribavirin plus amantadine for treatment of nonresponder patients with chronic hepatitis C.

    Published in:
    Journal of Gastroenterology, 2007, v. 42, n. 5, p. 362, doi. 10.1007/s00535-007-2006-3
    By:
    • Gramenzi, Annagiulia;
    • Andreone, Pietro;
    • Cursaro, Carmela;
    • Verucchi, Gabriella;
    • Boccia, Sergio;
    • Giacomoni, Pier Luigi;
    • Galli, Silvia;
    • Furlini, Giuliano;
    • Biselli, Maurizio;
    • Lorenzini, Stefania;
    • Attard, Luciano;
    • Bonvicini, Fiorenza;
    • Bernardi, Mauro
    Publication type:
    Article
    39
    40
    41
    42
    43
    44
    45

    Re-treatment of Patients With Chronic Hepatitis C Who Do Not Respond to Peginterferon-α2b.

    Published in:
    Annals of Internal Medicine, 2009, v. 150, n. 8, p. 528, doi. 10.7326/0003-4819-150-8-200904210-00007
    By:
    • Jensen, Donald M.;
    • Marcellin, Patrick;
    • Freilich, Bradley;
    • Andreone, Pietro;
    • Di Bisceglie, Adrian;
    • Brandão-Mello, Carlos E.;
    • Reddy, K. Rajender;
    • Craxi, Antonio;
    • Martin, Antonio Olveira;
    • Teuber, Gerlinde;
    • Messinger, Diethelm;
    • Thommes, James A.;
    • Tietz, Andreas
    Publication type:
    Article
    46
    47
    48

    Efficacy, safety, and pharmacokinetics of simeprevir, daclatasvir, and ribavirin in patients with recurrent hepatitis C virus genotype 1b infection after orthotopic liver transplantation: The Phase II SATURN study.

    Published in:
    Transplant Infectious Disease, 2017, v. 19, n. 3, p. n/a, doi. 10.1111/tid.12696
    By:
    • Forns, Xavier;
    • Berenguer, Marina;
    • Herzer, Kerstin;
    • Sterneck, Martina;
    • Donato, Maria Francesca;
    • Andreone, Pietro;
    • Fagiuoli, Stefano;
    • Cieciura, Tomasz;
    • Durlik, Magdalena;
    • Calleja, Jose Luis;
    • Mariño, Zoe;
    • Shukla, Umesh;
    • Verbinnen, Thierry;
    • Lenz, Oliver;
    • Ouwerkerk‐Mahadevan, Sivi;
    • Peeters, Monika;
    • Janssen, Katrien;
    • Kalmeijer, Ronald;
    • Jessner, Wolfgang
    Publication type:
    Article
    49
    50